Newtown, PA, United States of America

James Edward Sheppeck

USPTO Granted Patents = 27 

 

Average Co-Inventor Count = 4.3

ph-index = 8

Forward Citations = 137(Granted Patents)


Location History:

  • Willington, DE (US) (2005)
  • Wilmington, DE (US) (2004 - 2009)
  • Newton, PA (US) (2019)
  • Newtown, PA (US) (2006 - 2022)

Company Filing History:


Years Active: 2004-2022

Loading Chart...
Loading Chart...
27 patents (USPTO):

Title: James Edward Sheppeck: Innovator in Nonalcoholic Steatohepatitis Treatment

Introduction

James Edward Sheppeck, based in Newtown, PA, is a notable inventor and researcher recognized for his significant contributions to the field of pharmacology and therapeutic development. With an impressive portfolio of 27 patents, Sheppeck has played a pivotal role in advancing treatment options for various medical conditions, particularly focusing on nonalcoholic steatohepatitis (NASH).

Latest Patents

Among his latest patents, Sheppeck has developed innovative methods and compositions using sGC stimulators for the treatment of NASH. These patents describe the use of compounds that enhance soluble guanylate cyclase (sGC) activity, which are crucial for managing this liver disorder. The disclosed pharmaceutical compositions and kits can be used alone or in conjunction with other therapeutic agents, providing new avenues for effective treatment and management of NASH. Notably, the compounds described are identified as NO-independent, heme-dependent stimulators, expanding their therapeutic applications.

Career Highlights

Throughout his career, James Sheppeck has collaborated with prestigious companies such as Bristol-Myers Squibb Company and Cyclerion Therapeutics, Inc. His experiences in leading organizations have enriched his insights in pharmaceutical innovation and therapeutic research. He has consistently focused on developing novel approaches to enhance patient care and treatment efficacy.

Collaborations

In his inventive journey, Sheppeck has worked alongside esteemed colleagues like John L. Gilmore and Paul A. Renhowe. Their collaborative efforts have led to the successful development of innovative therapeutic solutions, particularly in the realm of Chronic Metabolic Disorders, further highlighting the importance of teamwork in scientific advancement.

Conclusion

James Edward Sheppeck stands out as a prominent inventor whose work is making a meaningful impact in medical research and therapeutic innovations. His contributions, especially in developing treatments for nonalcoholic steatohepatitis, demonstrate his commitment to improving health outcomes through science and innovation. As ongoing research continues to evolve, Sheppeck's work will undoubtedly play a crucial role in shaping future therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…